Interscalene Block With and Without Liposomal Bupivacaine in Shoulder Surgery

• Status: Completed
• Trial end date: 2020-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine the difference in perioperative pain after shoulder surgery with a standard bupivacaine nerve block compared to liposomal bupivacaine enhanced nerve block alone in TSA and ARCR. Data will be compared using VAS scores and opiate consumption between the two groups. The hypothesis of this study is that an interscalene nerve block with liposomal bupivacaine will decrease both postoperative VAS pain scores and total narcotic consumption when compared to a standard bupivacaine interscalene nerve block alone.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Orthopaedic & Neurosurgery Specialists
• Treatments: Anesthetics; Bupivacaine

Criteria

Inclusion Criteria:

• Patients over 18 undergoing rotator cuff repair or total shoulder arthroplasty

Exclusion Criteria:

• Pregnant

• Documented drug of alcohol abuse

• Active narcotic use prior to surgery

• Neurological deficit

• Allergy to amide anesthetics

• Not cleared by primary care physician

• Hydrocodone or oxycodone intolerance

• Enrollment in another clinical trial or past cognitive or mental health status that interferes with study